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Vitamin B12 deficiency among adult
diabetic patients in Uganda: relation to
glycaemic control and haemoglobin
concentration
George Patrick Akabwai1*, Davis Kibirige2, Levi Mugenyi3, Mark Kaddu1, Christopher Opio1, Rejani Lalitha1,
Edrisa Mutebi4 and Martha Sajatovic5
Abstract
Background: Vitamin B12 deficiency is highly prevalent among adult individuals with diabetes yet screening is
infrequent in Uganda. There are currently no published data regarding the prevalence of vitamin B12 deficiency
and its associated factors among adult individuals with diabetes in sub-Saharan Africa. This study aimed at
describing the prevalence and factors associated with vitamin B12 deficiency among this patient population in a
resource constrained setting in sub-Saharan Africa.
Methods: In this cross-sectional study, 280 eligible study participants attending the outpatient diabetic clinic at
Mulago national referral and teaching hospital in Kampala, Uganda were enrolled. Their socio-demographic, clinical
and laboratory data was collected using a pre-tested questionnaire.
Results: The majority of the study participants were female (68.9 %), with a median age of 50 (IQR: 40–58) years.
The mean (SD) serum vitamin B12 levels was 472.0 (16.4) pg/ml. The prevalence of vitamin B12 deficiency was 10.
7 %. Hemoglobin level < 12 g/dl (AOR 3.38; 95 % CI 1.38–8.32, p value = 0.008) and glycated hemoglobin ≥ 7 %
(AOR 3.29; 1.44–7.51, p value = 0.005) were associated with vitamin B12 deficiency.
Conclusions: Vitamin B12 deficiency is prevalent in approximately 1 in 10 of adult individuals with diabetes in
Uganda. We recommend screening for vitamin B12 deficiency among diabetic patients in Uganda especially those
with low hemoglobin concentrations and glycated hemoglobin levels ≥ 7 %.
Keywords: Vitamin B12 deficiency, Adults, Black, Individuals with diabetes, Africa, Uganda
Background
Vitamin B12 or cobalamin is a water soluble vitamin that
plays a very essential role in DNA synthesis, optimal hae-
mopoesis and neurological function [1]. Several studies
have unequivocally demonstrated that vitamin B12 defi-
ciency is highly prevalent in adult diabetic patients [2–4].
The most notable risk factor associated with vitamin B12
deficiency in adult individuals with diabetes in clinical prac-
tice is long term and high dose metformin therapy [4–6].
Clinically overt and untreated vitamin B12 deficiency has
been associated with disabling sensory polyneuropathy
which mimics diabetic neuropathy, anaemia, depression,
cognitive dysfunction [1, 7, 8].
Despite the above recognised clinical conditions associ-
ated with vitamin B12 deficiency and its high frequency in
adult individuals with diabetes, there are no global guide-
lines recommending routine assessment of serum vitamin
B12 levels. In sub Saharan Africa (SSA), a region with a
high frequency of nutritional deficiencies, there is a dearth
of data on the burden and predictors of vitamin B12 defi-
ciency in adult individuals with diabetes.
We therefore sought to determine the prevalence and
associated factors of vitamin B12 deficiency in 280 adult
individuals with diabetes attending the outpatient diabetic
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clinic at Mulago national referral and teaching hospital in
Kampala, Uganda.
Methods
Between 1st May and 31st September 2014, we performed
a cross sectional study to assess vitamin B12 levels and re-
lated clinical factors in the outpatient diabetic clinic of
Mulago national referral and teaching hospital, Kampala
Uganda. The clinic is run every Wednesday and an aver-
age of 80 adult patients is reviewed on each clinic day.
Patients enrolled into the study were: ambulatory with
documented evidence of DM and had regularly been
attending the clinic for at least the past 6 months,
aged ≥ 18 years and had offered informed consent. Patients
on vitamin B12 replacement therapy or multi vitamin sup-
plementation were excluded.
Sample size and sampling technique
A consecutive sampling method was used during the
recruitment process of the eligible patients until the
desired sample size of 280 was obtained. Using the
Kish-Leslie formula (1995) of n = Z2Pq/d2 (n = Sample
size, Z =1.96, the normal value corresponding to the
95 % confidence interval, P = 0.22-prevalence of vitamin
B12 deficiency of 22 % from a study by Pflipsen M et al.
[2] in adult individuals with diabetes, q = 1-p and d = 5 %,
the desired precision of estimation), a sample size of a
minimum of 264 patients was obtained. We increased the
sample size to 280 patients.
Data collection
A questionnaire in English or Luganda, the commonly
spoken local dialect in the region was administered to
the study participants. The translation of the question-
naires from English to Luganda was done by someone
fluent in the language and adept in questionnaire trans-
lation. The translated questionnaires were pre tested to
ensure validity of the results to be obtained.
Information obtained included key socio-demographic
characteristics like age, gender, employment and educa-
tion status, clinical signs and symptoms related to vita-
min B12 deficiency, past medical and drug history,
family history of DM and hypertension and lifestyle and
social activities such as alcohol intake and smoking. Par-
ticipants’ weight in kilograms (kg) and height in metres
(m) were measured using a calibrated weight scale and
height board respectively and their body mass indexes
(BMI) calculated using the formula below; BMI = kg/m2.
Laboratory analysis
Six millilitres of blood were drawn by an experienced
laboratory technician and sent for analysis. The complete
blood count (CBC) and peripheral film comment were
done by an experienced haematologist in the haematology
laboratory of Mulago hospital. Serum vitamin B12 levels,
the outcome variable, glycated haemoglobin (HbA1c),
fasting lipid profile, renal and liver function tests were
analysed from the clinical chemistry laboratory of Mulago
hospital using the Roche diagnostics Elecsys© immunoas-
says. The main outcome of this study was vitamin
B12 deficiency defined as serum vitamin B12 serum
levels < 200 pg/ml. Borderline vitamin B12 deficiency
and normal vitamin B12 levels were defined as vitamin
B12 levels between 200 and 300 pg/ml and >300 pg/ml
respectively.
Statistical analysis
Pre-coded data were entered using EPI-DATA 3.1 and
were exported to statistical package, STATA 10, for stat-
istical analysis with the help of a statistician. Age was
presented as median as this was not normally distributed
and grouped onto age categories for further analysis.
Categorical variables were analyzed and presented as fre-
quencies and percentages. They were compared using the
chi-square and Fisher’s exact tests as appropriate. At bi-
variable analysis, variables with a p vaues ≤ 0.2 were sub-
jected to multivariable analysis using a logistic regression
and model building done using a likelihood ratio test.
The prevalence of vitamin B12 deficiency was expressed
as the proportion of study participants with serum vitamin
B12 levels < 200 pg/ml divided by the total number of par-
ticipants enrolled into the study. A p-value of 0.05 was
considered statistically significant.
Results
Socio demographic and clinical characteristics of study
participants
Of the 280 study participants enrolled into the study,
there was a female predominance (193, 68.9 %). The me-
dian age (IQR) for the study participants was 50 (40–58)
years. The majority of the study participants were urban
dwellers (175, 62.5 %), unemployed (147, 52.7 %) and had
attained primary level education (137, 48.9 %) (summarised
in Table 1).
The most frequent clinical symptoms were paraesthesias
(227, 81.1 %), forgetfulness (24, 8.57 %) and tiredness even
after light exertion (14, 5 %). Others included irritability
(12, 4.3 %) and gait abnormality (11, 3.9 %). Clinical pallor
of the mucous membranes and palmar pigmentation were
observed in only 8 (2.86 %) and 3 (1.1 %) study partici-
pants respectively. Hypertension, prior use of proton
pump inhibitors (PPIs) and HIV infection were docu-
mented in 188 (67 %), 73 (26 %) and 17 (6.1 %) study par-
ticipants respectively. Family history of hypertension and
diabetes was reported in 200 (71.4 %) and 187 (66.8 %)
participants respectively. Most participants were type 2 di-
abetics (224, 81.5 %).
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Vitamin B12 status of the study participants
The mean (SD) serum vitamin B12 level of the study
participants was 472 (16.4) pg/ml. Vitamin B12 defi-
ciency, borderline vitamin B12 deficiency and normal
vitamin B12 levels were documented in 30 (10.7 %), 42
(15 %) and 208 (74.3 %) participants respectively. A total
of 72 (25.7 %) participants had suboptimal vitamin B12
levels, defined as vitamin B 12 levels < 300 pg/ml. All
these study participants had never had a serum vitamin
B12 measurement performed before.
Socio-demographic and clinical characteristics of the
study participants at bivariable analysis
At bivariable analysis, neither socio-demographic nor clin-
ical characteristics were associated with vitamin B 12 defi-
ciency. (Tables 2 and 3 summarizes the socio-demographic
and clinical characteristics of the study participants in asso-
ciation with vitamin B12 levels at bivariable analysis).
Laboratory findings of the study participants at bivariable
analysis
A statistically significant association with vitamin B12
deficiency was observed with hemoglobin concentra-
tion < 12 g/dl (p = 0.001), WBC counts > 4000 cells/mm3
(p = 0.017) and glycated hemoglobin ≥ 7 % (p = 0.001).
Paradoxically, a high mean cell volume (MCV) ≥ 100 was
infrequent in participants with vitamin B12 deficiency
(1, 3.4 %). The majority had normal MCV levels (18,
62.1 %). No study participant with vitamin B12 deficiency
had the classical findings of macrocytosis, ovalocytosis and
hyper segmented WBCs on peripheral blood film assess-
ment (Table 4 summarizes the laboratory findings of the
study participants in association with vitamin B12 levels at
bivariable analysis).
Factors significantly associated with vitamin B12 levels at
multivariable analysis
At multivariable analysis, the statistically significant factors
associated with vitamin B12 deficiency were: hemoglobin
concentration < 12 g/dl (adjusted OR-3.38; 95 % CI 1.38–
8.31, p vaue = 0.008) and glycated hemoglobin ≥ 7 %
(adjusted OR-3.29; 95 % CI 1.44–7.51, p vaue = 0.005), as
summarised in Table 5.
Discussion
Burden of vitamin B12 deficiency
To our knowledge, this is the first study to describe the
burden of vitamin B12 deficiency and its associated factors
in adult individuals with diabetes in sub Saharan Africa, a
region with a high frequency of nutritional deficiencies
[9, 10]. In this cross sectional study, we report a preva-
lence of vitamin B12 deficiency of 10.7 % among adult
individuals with diabetes attending the outpatient dia-
betic clinic of Mulago national referral and teaching
hospital in Uganda. Haemoglobin concentration < 12 g/dl
and glycated hemoglobin ≥ 7 % were noted to be inde-
pendently associated with vitamin B12 deficiency.
Varied prevalence of vitamin B12 deficiency in adult
individuals with diabetes has been described by studies
performed in different countries outside Africa [2–4, 6,
11–13]. In comparison to the findings in our study,
higher frequencies of vitamin B12 deficiency have been
reported in U.S. and European studies. A cross sectional
Table 1 Demographic characteristics of the study participants
(N = 280)
Characteristic n (%)
Age, median (IQR) 50 (18)
Gender, n (%) Female 193 (68.9)
Address, n (%) Rural 105 (37.5)
Urban 175 (62.5)
Education level, n (%) None 31 (11.1)
Primary 137 (48.9)
Secondary 100 (35.7)
Post-secondary 12 (4.3)
Religion, n (%) Muslim 72 (25.8)
Catholic 86 (30.8)
Anglican 86 (30.8)
Born again 35 (12.5)
Occupation, n (%) Employed 133 (47.5)
Unemployed 147 (52.5)
Marital status, n (%) Married 156 (55.7)
Cohabiting 10 (3.6)
Single 28 (10.0)
Divorced 41 (14.6)
Widow/widowed 45 (16.1)
Table 2 Vitamin B12 deficiency in relation to socio-
demographic characteristics at bivariable analysis
Characteristic <200 pg/ml
N = 30 (%)
≥200 pg/ml
N = 250 (%)
P value
Age in years <40 4 (13.3) 72 (28.8) 0.137
40–60 18 (60.0) 136 (54.4)
>60 8 (26.7) 42 (16.8)
Sex Male
Female
6 (20.0)
24 (80.0)
81 (32.4)
169 (67.6)
0.166
Address Rural
Urban
9 (30.0)
21 (70.0)
96 (38.4)
154 (61.6)
0.369
Education level None/primary
Post primary
19 (63.3)
11 (36.7)
149 (59.6)
101 (40.4)
0.693
Religion Muslim
Catholic
Anglican
Born-again
7 (23.3)
11 (36.7)
9 (30.0)
3 (10.0)
65 (26.1)
75 (30.1)
77 (30.9)
32 (12.9)
0.889
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study by Pflipsen et al. involving 203 outpatient type 2
diabetic patients at a large military primary care clinic in
USA documented a prevalence of definite vitamin B12
deficiency of 22 % [2]. Similar studies done in Europe
have reported prevalence of about 27 % [12, 13].
The apparently higher prevalence in the European and
American studies compared to ours was likely at least in
part because of differential cut-offs for categorizing defi-
cient vitamin B12 levels. The study by Pflipsen et al. per-
formed in the USA defined definite vitamin B12 deficiency
as serum vitamin B12 concentrations of <100 pg/ml or ele-
vated serum methylmalonic acid of >243 nmol/L or homo-
cysteine concentrations of >11.9 nmol/L if serum vitamin
B12 concentrations were between 100 and 350 pg/mL [2].
Therefore, the prevalence in this study would have been
higher using a similar cut off < 200 pg/ml.
Differential prevalence rates of vitamin B12 deficiency
could also be due to genetic influences and differences
in dietary intake (low dietary intake of foods rich in vita-
min B12 like meat).
Comparable prevalence of vitamin B12 deficiency of
9.5–14.2 % has been reported in similar studies among
South Korean [3, 11] and Indian [12] adult individuals
with diabetes. However, despite the comparable prevalence
noted in the South Korean studies [3, 11], different study
definitions of vitamin B12 deficiency were used (serum
vitamin B12 levels ≤300 pg/mL without folate deficiency).
In Uganda, the burden of vitamin B12 deficiency has
previously been studied in 2 patient populations: psychi-
atric patients who had a prevalence rate of 28.6 % [14] and
outpatient HIV infected patients who had a prevalence rate
of 10.3 % [15]. The study in psychiatric patients defined
vitamin B12 deficiency as serum vitamin B12 levels
<240 pg/ml which likely accounted for the apparently
higher rates compared to our study of diabetic outpatients.
Factors associated with vitamin B12 deficiency at
bivariable and multivariable analysis
At bivariable analysis, a statistically significant associ-
ation with vitamin B12 deficiency was observed with
hemoglobin level < 12 g/dl, glycated hemoglobin ≥ 7 %
and WBC count. However, at multivariable analysis,
hemoglobin level and glycated hemoglobin retained stat-
istical significance.
Table 3 Vitamin B12 deficiency in relation to clinical
characteristics at bivariable analysis
Characteristic <200 pg/ml,
n (%)
≥200 pg/ml,
n (%)
P value
Paraesthesias No 4 (13.3) 49 (19.6) 0.621
Yes 26 (86.7) 201 (80.4)
Forgetfulness No 28 (93.3) 228 (91.2) >0.999
Yes 2 (6.7) 22 (8.8)
Tiredness No 30 (100) 236 (94.4) 0.376
Yes 0 (0.0) 14 (5.6)
Gait No 27 (90.0) 242 (96.8) 0.101
Yes 3 (10.0) 8 (3.2)
Irritability No 29 (96.7) 238 (95.6) >0.999
Yes 1 (3.3) 11 (4.4)
Pallor No 28 (93.3) 244 (98.6) 0.207
Yes 2 (6.7) 6 (2.4)
Hypertension No 9 (30.0) 82 (32.8) 0.757
Yes 21 (70.0) 168 (67.2)
HIV No 28 (93.3) 235 (94.0) 0.701
Yes 2 (6.7) 15 (6.0)
Family history of
DM
No 12 (40.0) 81 (32.4) 0.404
Yes 18 (60.0) 169 (67.6)
Family history of
HT
Yes 10 (33.3) 68 (27.4) 0.496
No 20 (66.7) 180 (72.6)
Current
medication
Metformin alone 7 (23.3) 41 (16.4) 0.726
Metformin & SU 12 (40.0) 78 (31.2)
Metformin & SU
& Pio
1 (3.3) 9 (3.6)
Insulin alone 6 (20.0) 68 (27.2)
Insulin &
metformin
4 (13.3) 50 (20.0)
Statins 0 (0.0) 4 (1.6)
Age at diagnosis
(years)
<40 8 (26.7) 98 (39.2) 0.144
40–60 21 (70.0) 129 (51.6)
>60 1 (3.3) 23 (9.2)
Duration since
diagnosed (years)
<2 7 (23.3) 59 (23.6) 0.234
2–4 6 (20.0) 85 (34.0)
5–7 3 (10.0) 32 (12.8)
>7 14 (46.7) 74 (29.6)
BMI Kg/m2 <18.5 2 (6.7) 18 (7.2) 0.939
18.5–24.9 10 (33.3) 96 (38.6)
25.0–29.9 10 (33.3) 71 (28.5)
≥30.0 8 (26.7) 64 (25.7)
Blood pressure
(mmHg)
≤140/80 11 (36.7) 115 (46.0) 0.332
>140/80 19 (63.3) 135 (54.0)
Metformin alone
(N = 48)
≤3 years 4 (57.1) 27 (65.9) 0.657
>3 years 3 (42.9) 14 (34.2)
Table 3 Vitamin B12 deficiency in relation to clinical
characteristics at bivariable analysis (Continued)
Metformin & SU
(N = 90)
≤3 years 5 (41.7) 41 (52.6) 0.484
>3 years 7 (58.3) 37 (47.4)
Insulin alone
(N = 74)
≤3 years 5 (83.3) 32 (47.1) 0.124
>3 years 1 (16.7) 36 (52.9)
Abbreviations: DM diabetes mellitus, HT hypertension, BMI body mass index, SU
sulphonylurea, Pio pioglitazone, PPIs proton pump inhibitors
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Hematological derangements presenting either as a lone
cytopenia or pancytopenia are a common finding in
patients with vitamin B12 deficiency. Vitamin B12 is
an essential micronutrient required in DNA synthesis,
cellular repair and optimal haemopoesis together with other
micronutrients like folate and iron. In addition to pancyto-
penia, other overt hematological findings like macrocytic
red blood cells (mean cell volume [MCV] > 100 fl) with/
without anemia, ovalocytes and hyper segmented white
blood cells (i.e. >5 % of neutrophils with ≥5 lobes) are also
very frequent. However, these hematological derangements
are usually preceded by neurological manifestations like ir-
ritability, gait disturbances and paraesthesias [1, 16], which
were highly prevalent in our study population.
Contradictorily, raised MCV levels were uncommon
among the participants with vitamin B12 deficiency in
our study. This could be due to the high prevalence of
co-existing iron deficiency anemia in SSA arising from
poor dietary intake and helminth infestation [10]. We
did not however perform a comprehensive dietary as-
sessment, serum ferritin level measurement and stool
examination for ova and cysts in this study.
Glycated hemoglobin and vitamin B12 deficiency
Glycated haemoglobin level ≥ 7 % which reflects subopti-
mal glucose control in adult individuals with diabetes
was associated with vitamin B12 deficiency in this study
population. Compelling evidence from several studies
have associated vitamin B12 deficiency and accompany-
ing hyperhomocysteinemia with increased oxidative
stress and insulin resistance which collectively result into
suboptimal glycaemic control [17–19]. Studies have also
demonstrated that low maternal vitamin B12 levels in
early pregnancy are often associated with offspring insulin
resistance and future DM [20, 21]. The speculative mech-
anism to explain this is epigenetic modifications due to
absence of methionine, a ubiquitous 1-carbon donor to
numerous methylation reactions, including DNA methyla-
tion. This contributes to elevation in insulin resistance as
has been suggested in animal models [22].
Other studies have demonstrated a close association
between vitamin B 12 deficiency and long term use and
high dose metformin therapy [3–6, 11, 13, 23]. Metformin
Table 4 Vitamin B12 deficiency in relation to laboratory findings
at bivariable analysis
Characteristic <200 pg/ml
n (%)
≥200 pg/ml
n (%)
P value
Haemoglobin, g/dl ≥12.0 18 (60.0) 211 (84.4) 0.001
<12.0 12 (40.0) 39 (15.6) –
WBC count, cells/mm3 <4 5 (16.7) 13 (5.3) 0.017
≥4 25 (83.3) 234 (94.7) –
Mean cell volume, fl <79.9 10 (34.5) 63 (25.6) 0.186
80–99.9 18 (62.1) 181 (73.3) –
≥100 1 (3.4) 3 (1.2) –
Red cell distribution
width, %
<17 29 (96.7) 246 (98.8) 0.367
≥17 1 (3.3) 3 (1.2) –
FBS level, mmol/l <7 9 (30.0) 62 (25.2) 0.570
≥7 21 (70.0) 184 (74.8) –
HbA1c, % <7 16 (53.3) 59 (23.7) 0.001
≥7 14 (46.7) 190 (76.3) –
LDLC, mmol/l <2.6 8 (26.7) 59 (24.1) 0.756
≥2.6 22 (73.3) 186 (75.9) –
TGL, mmol/l <1.7 16 (53.3) 106 (43.3) 0.295
≥1.7 14 (46.7) 139 (56.7) –
Total cholesterol, mmol/l <5 14 (46.7) 128 (51.6) 0.594
≥5 16 (53.3) 119 (48.2) –
HDLC, mmol/l <1 11 (36.7) 62 (25.3) 0.183
≥1 19 (63.3) 183 (74.7) –
Serum creatinine, μmol/l <125 28 (93.3) 236 (96.3) 0.342
≥125 2 (6.7) 9 (3.7) –
Serum urea, mmol/l <6.5 28 (96.6) 219 (90.9) 0.486
≥6.5 1 (3.5) 22 (9.1) –
ALT, U/L <60 30 (100) 245 (99.6) >0.999
≥60 0 (0) 1 (0.4) –
AST, U/L <60 27 (93.1) 243 (99.2) 0.057
≥60 2 (6.9) 2 (0.8) –
Albumin, g/L <35 2 (6.7) 15 (6.1) >0.999
≥35 28 (93.3) 232 (93.9) –
HIV serology No 28 (93.3) 232 (94.3) 0.688
Yes 2 (6.7) 14 (5.7) –
Abbreviations: WBC white blood cell, FBS fasting blood sugar, HbA1c glycated
haemoglobin, LDLC low density lipoprotein cholesterol, TGL triglycerides, HDLC
high density lipoprotein cholesterol, ALT alanine transaminases, AST aspartate
transaminases, HIV human immunodeficiency virus
Table 5 Unadjusted and adjusted odds ratios for predictors of
B12 deficiency using a logistic regression
Unadjusted Adjusted
OR (95 % CI) p value OR (95 % CI) p value
Haemoglobin (g/dl)
≥ 12.0 1 – 1 –
< 12.0 3.61 (1.61–8.08) 0.002 3.38 (1.38–8.31) 0.008
HbA1ca
< 7 1 – 1 –
≥ 7 3.68 (1.69–7.98) 0.001 3.29 (1.44–7.51) 0.005
WBCb count (/mm3)
< 4 1 – 1 –
4–11 0.28 (0.09–0.84) 0.024 0.37 (0.10–1.38) 0.138
Controlled for age and gender variables
aHbA1c-glycated haemoglobin
bWBC-White blood cell
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has been shown to reduce calcium bioavailability which
affects ileal vitamin B12 absorption [1, 24]. In our study,
this association was not observed probably because there
were few patients on metformin therapy.
Study limitations
The diagnosis of vitamin B12 deficiency is best assessed
using levels of serum homocysteine and methylmalonic
acid which helps identify patients with borderline (low
normal) levels. Unfortunately, we were unable to perform
these tests because they are not readily available in
Uganda. The study was performed from a single study site
or urban hospital based. Therefore, these results cannot
be extrapolated to other hospitals and the general non-
clinical population at a national level. Finally, the cross-
sectional design could not establish a cause-effect relation-
ship between vitamin B12 deficiency and other clinical
factors such as diabetes control. Even though more num-
bers of study participants were enrolled than the desired
number, the study still faces a limitation of small sample
size particularly in some of the individual cell sizes.
Conclusions
Vitamin B12 deficiency occurs in approximately 1 in 10 of
adult ambulatory individuals with diabetes receiving care
in a Ugandan national referral hospital. Low hemoglobin
concentrations < 12 g/dl and elevated glycated hemoglobin
levels ≥ 7 % (suboptimal glycaemic control) were associ-
ated with vitamin B12 deficiency. Elevated MCV levels
and red blood cell changes like macrocytosis and hyper
segmented WBCs were not as prevalent as expected in pa-
tients with vitamin B12 deficiency. Given the relatively
high rates and known potential problems associated with
vitamin B12 deficiency, we recommend screening for
all adult individuals with diabetes, especially in those
with suboptimal diabetes control and anemia. We also
recommend a prospective representative multi-centre
study to assess the prevalence of vitamin B12 deficiency in
individuals without diabetes as controls compared to
those with diabetes and to examine the effect of vitamin
B12 deficiency on optimal glycaemic control and worsen-
ing of insulin resistance among individuals with diabetes.
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